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ABSTRACT A method for site-specific, nitrobenzyl-
induced photochemical proteolysis of diverse proteins ex-
pressed in living cells has been developed based on the
chemistry of the unnatural amino acid (2-nitrophenyl)glycine
(Npg). Using the in vivo nonsense codon suppression method
for incorporating unnatural amino acids into proteins ex-
pressed in Xenopus oocytes, Npg has been incorporated into
two ion channels: the Drosophila Shaker B K1 channel and the
nicotinic acetylcholine receptor. Functional studies in vivo
show that irradiation of proteins containing an Npg residue
does lead to peptide backbone cleavage at the site of the novel
residue. Using this method, evidence is obtained for an
essential functional role of the ‘‘signature’’ Cys128–Cys142
disulfide loop of the nAChR a subunit.
A powerful tool for probing protein structure and function is
the incorporation of unnatural amino acids by the method of
nonsense suppression, a technique developed for in vitro
translation systems by Schultz and coworkers (1–3). Recent
work has expanded the scope of this methodology by estab-
lishing procedures for unnatural amino acid incorporation into
proteins expressed in living cells (4–7). This allows the eval-
uation of neuroreceptors, ion channels, and related proteins
that are studied most effectively in vivo using heterologous
expression systems such as the Xenopus oocyte. The suppres-
sion methodology is especially promising for such integral
membrane proteins, which are not yet generally amenable to
the methods of high resolution structure determination (e.g.,
NMR, x-ray crystallography).
In this paper we (i) describe the unnatural amino acid
2-(nitrophenyl)glycine (Npg) and show that it can be efficiently
incorporated into proteins expressed in vivo; (ii) establish that
in vivo irradiation of an Npg-containing protein leads to
site-specific, nitrobenzyl-induced photochemical proteolysis
(SNIPP) (Fig. 1); and (iii) illustrate the usefulness of this
residue by cleavage of the Cys128–Cys142 ‘‘signature’’ disul-
fide loop of the nicotinic acetylcholine receptor, establishing
a crucial functional role for this structural feature.
The design of the unnatural amino acid Npg was based on
the photochemistry of 2-nitrobenzyl derivatives. Compounds
of this type, including Npg itself, have been used as protecting
groups in organic synthesis and to produce ‘‘caged’’ neuro-
transmitters, ions, and second messengers that can then be
liberated photochemically, but, to our knowledge, Npg has not
been incorporated into peptides or proteins (8–17). As shown
in Fig. 1, incorporation of Npg into a protein, followed by
irradiation of the protein, was anticipated to produce peptide
backbone cleavage (18) by analogy to other 2-nitrobenzyl
systems (For an example of photochemically initiated protein
self-splicing reaction, see ref. 18.)
METHODS
Synthesis of Npg–tRNA. D,L-(2-Nitrophenylglycine)Hydro-
chloride. The unnatural amino acid D, L-(2-nitrophenylglycine)
hydrochloride was prepared according to published proce-
dures (19–20).
N-4PO-D,L-(2-Nitrophenyl)Glycine. The amine of N-4PO-
D,L-(2-nitrophenyl)glycine was protected as the N-pent-4-
enoyl (4PO) derivative using standard conditions (21, 22).
Na2CO3 (111 mg, 1.05 mmol) was added to a room tempera-
ture solution of (2-nitrophenyl)glycine hydrochloride (82 mg,
0.35 mmol) in H2O:dioxane (0.75 ml:0.5 ml), followed by a
solution of pent-4-enoic anhydride (70.8 mg, 0.39 mmol) in
dioxane (0.25 ml). After 3 h, the mixture was poured into
saturated NaHSO4 and extracted with CH2Cl2. The organic
phase was dried over anhydrous Na2SO4 and concentrated in
vacuo. The residual oil was purified by flash silica gel column
chromatography to yield the title compound (73.2 mg, 75.2%)
as a white solid. 1H NMR (300 MHz, CD3OD) d 8.06 (dd, J 5
1.2, 8.1 Hz, 1H), 7.70 (ddd, J 5 1.2, 7.5, 7.5 Hz, 1H), 7.62–7.53
(m, 2H), 6.21 (s, 1H), 5.80 (m, 1H), 5.04–4.97 (m, 2H), and
2.42–2.28 (m, 4H). High resolution mass spectometry calcu-
lated for C13H14N2O5 279.0981 found 279.0992.
N-4PO-D,L-(2-Nitrophenyl)Glycinate Cyanomethyl Ester. N-
4PO-D,L-(2-nitrophenyl)glycine was activated as the cyano-
methyl ester using standard conditions (5, 23). NEt3 (95 ml,
0.68 mmol) was added to a room temperature solution of the
acid (63.2 mg, 0.23 mmol) in anhydrous DMF (1 ml), followed
by addition of ClCH2CN (1 ml). After 16 h, the mixture was
diluted with Et2O and extracted against H2O. The organic
phase was washed with saturated NaCl, dried over anhydrous
Na2SO4, and concentrated in vacuo. The residual oil was
purified by flash silica gel column chromatography to yield the
title compound (62.6 mg, 85.8%) as a yellow solid. 1H NMR
(300 MHz, CDCl3) d 8.18 (dd, J 5 1.2, 8.1 Hz, 1H), 7.74–7.65
(m, 2H), 7.58 (ddd, J 5 1.8, 7.2, 8.4 Hz, 1H), 6.84 (d, J 5 7.8
Hz, 1H), 6.17 (d, J 5 6.2 Hz, 1H), 5.76 (m, 1H), 5.00 (dd, J 5
1.5, 15.6 Hz, 1H), 4.96 (dd, J 5 1.5, 9.9 Hz, 1H), 4.79 (d, J 5
15.6 Hz, 1H), 4.72 (d, J 5 15.6 Hz, 1H), and 2.45–2.25 (m, 4H).
High resolution mass spectometry calculated for C16H17N3O5
317.1012 found 317.1004.
N-4PO-(2-Nitrophenyl)Glycine-dCA. The dinucleotide dCA
N-4PO-(2-nitrophenyl)glycine-dCA was prepared as reported
by Schultz (24) with the modifications described by Kearney
(5). The cyanomethyl ester was coupled to dCA according to
a standard protocol (5, 23). N-4PO-D,L-(2-nitrophenyl)glyci-
nate cyanomethyl ester (16.3 mg, 51.4 mmol) was added to a
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room temperature solution of dCA (tetrabutylammonium salt,
20 mg, 16.6 mmol) in anhydrous DMF (400 ml) under argon.
The resulting deep red solution was stirred for 1 h and then
quenched with 25 mM NH4OAc (20 ml, pH 4.5). The crude
product was purified by reverse-phase semi-preparative HPLC
(Whatman Partisil 10 ODS-3 column, 9.4 mm 3 50 cm) using
a gradient from 25 mM NH4OAc (pH 4.5) to CH3CN. The
appropriate fractions were combined and lyophilized. The
resulting solid was redissolved in 10 mM HOAcyCH3CN and
lyophilized to afford 4PO–Npg–dCA (3.9 mg, 8.8%) as a pale
yellow solid: electrospray ionization-MS: M2 896 (31) [M-H]2
895 (100); calculated for C32H36N10O17P2 896. The material
was quantified by UV absorption («260 ' 37,000).
N-4PO-(2-Nitrophenyl)Glycine-tRNA. The tRNA gene used
was Tetrahymena thermophila tRNAGlnCUA having a G at
position 73 in the plasmid pTHG73 (6). This gene contains an
upstream T7 RNA polymerase promotor and a downstream
Fok I restriction site. Digestion of pTHG73 with Fok I
provided the linearized template DNA lacking the 39-terminal
CA at positions 75 and 76. In vitro transcription of the
linearized transcript and purification of the truncated THG73
tRNA product was performed as described (6). Ligation of
4PO–Npg-dCA to the THG73 runoff transcript was accom-
plished using T4 RNA ligase (New England Biolabs) as
described (6).
(2-Nitrophenyl)Glycine-tRNA. Deprotection of 4PO–Npg–
tRNA was performed just before injection according to the
method described by Fraser–Reid (21). A saturated solution of
iodine (0.50 ml, 1.2 mM) was added to a room temperature
solution of 4PO–Npg–tRNA (0.5 ml). After 10 min, the
resulting Npg–tRNA was immediately mixed with the desired
mRNA (1.0 ml).
Mutagenesis and mRNA Synthesis. PCR mutagenesis was
used to generate cassettes containing the Shaker B (ShB)-
Leu47TAG, ShB-Pro64TAG, and a-Val132TAG amber mu-
tations. Cassettes were trimmed with appropriate restriction
enzymes, purified, and ligated into the parent construct (ShBy
pAMV-PA or aypAMV-PA) that had been previously di-
gested with the same restriction enzymes and dephosphory-
lated. Mutations were verified by automated sequencing over
the entire amplified region and the ligation sites. The
bLeu99TAG amber mutation was prepared using the CLON-
TECH Transformer kit and was transferred into pAMV-PA.
The pAMV-PA vector is a modified pBS (SyK1) vector
containing an alfalfa mosaic virus region directly upstream
from the coding region of the insert and an A50 sequence
downstream from the insert. Plasmid DNAs were linearized
with NotI, and mRNA was transcribed using the Ambion
(Austin, TX) T7 mMESSAGE mMACHINE machine Kit.
mRNAs were dissolved in sterile water and quantitated by UV
absorption (A260). Restriction enzymes were purchased from
Boehringer, and Pfu polymerase was purchased from Strat-
agene.
Oocyte Injections. Oocytes were removed from Xenopus
laevis as described (25) and maintained at 18°C in ND96
solution (96 mM NaCly2 mM KCly1.8 mM CaCl2y1 mM
MgCl2y5 mM Hepesy2.5 mM sodium pyruvatey0.5 mM the-
ophylliney50 mg/ml gentamycin, pH 7.5, with NaOH). Just
before microinjection, the 4PO–Npg–tRNA was deprotected
(as described above) and combined with the appropriate
mRNA. Oocytes were microinjected (50 nl) with the following
mRNA and tRNA concentrations: ShB-Pro64TAG (0.4 ngynl)
or ShB-Leu47TAG (0.4 ngynl) and Npg–tRNA (1.0 ngynl);
ShB-wild type [1 pgynl; Fig. 2B (all concentrations are divided
by two for Fig. 2C)]; nAChR-b99TAG (0.017 ngynl total
mRNA; a:b:g:d ratio, 2:1:1:1); Npg–tRNA (1.0 ngynl); wild-
type nAChR (1.6 pgynl); nAChR-aVal132TAG (0.094 ngynl
total mRNA; a:b:g:d ratio, 12:1:1:1); and Npg–tRNA (1.0
ngynl). For the nAChR-aVal132TAG experiments, oocytes
were injected three times (at 0, 24, and 48 h) before recording
and [125I]-a-bungarotoxin binding (at 72 h). Oocytes were
assayed '24 h after injection (ShB-Pro64TAG, ShB-
Leu47TAG, ShB-wild type, nAChR-b99TAG, wild-type
nAChR) or '72 h after injection (nAChR-aVal132TAG).
Oocyte Irradiation and Electrophysiology. Oocytes were
irradiated at 4°C in 1y2-dram Pyrex vials with a 288-W Hg
lamp (BLAK-RAY Longwave Ultraviolet Lamp, Ultraviolet
Products, San Gabriel, CA) equipped with a 360-nm band pass
filter at a distance of 15–30 cm for 4 h unless otherwise
indicated. Nonirradiated oocytes were maintained at 4°C for
the corresponding period of time. Whole-cell currents from
oocytes were measured using a Geneclamp 500 amplifier
(Axon Instruments, Foster City, CA) in the 2-electrode volt-
age–clamp configuration. Current and voltage electrodes were
filled with 3 M KCl to yield resistances ranging from 0.5 to 1.5
mV. Holding potential was 280 mV. Oocytes were continu-
ously perfused with a nominally calcium-free bath solution
consisting of 96 mM NaCl, 2 mM KCl, 1 mM MgCl2 and 5 mM
Hepes (pH 7.5). Atropine (1 mM) was added to the bath
solution for the nAChR recordings. ShB peak and steady-state
current values were obtained using CLAMPFIT from PCLAMP 6.0
(Axon Instruments). Macroscopic acetylcholine-induced cur-
rents were recorded in response to bath application of the
indicated agonist concentration at 280 mV. All numerical and
plotted data are from measurements obtained from several
oocytes (three to eight for K1 channel studies and at least eight
for nAChR studies) and are reported as mean 6 SEM.
[125I]-a-Bungarotoxin Binding. [125I]-a-bungarotoxin (10
nM) binding was carried out in PBS (1 mM CaCl2) for 1.5 h at
room temperature.
RESULTS AND DISCUSSION
To establish the viability of SNIPP, Npg was incorporated into
the Drosophila ShB K1 ion channel (26–31). The ShB channel
is formed from four identical subunits, each of which contains
six transmembrane domains and the reentrant ‘‘P’’ region (Fig.
2). A hallmark of this voltage-gated channel is rapid (N-type)
inactivation, which terminates openings induced by changes in
the transmembrane potential. Aldrich and coworkers estab-
lished the molecular transitions that underlie N-type inactiva-
tion as involving a ‘‘ball-and-chain’’ mechanism (Fig. 2) (32–
35). The first 20 amino acids in the NH2 terminus form a
structural domain that interacts with part of the open channel
to cause inactivation on a millisecond time scale. This struc-
tural domain, or ‘‘ball’’ region, is connected to the rest of the
protein by a ‘‘chain’’ sequence of 60 or more amino acids that
tethers the inactivation ball near the channel pore. Deletion of
a section of this region (D6–46) produces a well characterized
channel termed ‘‘Shaker-IR’’ (IR 5 inactivation removed) that
does not inactivate on a millisecond time scale.
With the intent of transforming ShB subunits to Shaker-IR
subunits by SNIPP in an intact cell, we introduced Npg into
FIG. 1. Schematic of the photochemical cleavage of a protein
backbone using the Npg residue.
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either of two sites (Leu47 and Pro64) in the chain region of
ShB (Fig. 2). Xenopus oocytes thus expressed mutant ShB K1
channels comprised of either ShB-Leu47Npg (i.e., ShB with a
TAG codon at position 47, normally a Leu residue, suppressed
by Npg-tRNA, which has the CUA anticodon) or ShB-
Pro64Npg subunits. These mutant channels displayed activa-
tion and inactivation kinetics equivalent to those of wild-type
ShB channels. Irradiation of oocytes expressing either mutant
channel resulted in K1 currents with reduced levels and rates
of inactivation, and both of these effects increased in the
expected manner (35) with increased irradiation time (Fig. 2).
Irradiation of wild-type ShB K1 channels expressed in Xenopus
oocytes produced no change in either level or rate of inacti-
vation.
Given the established photochemistry of the 2-nitrobenzyl
group (8–16) and the well characterized Shaker-IR phenotype
(26–35), these results provide convincing evidence that irra-
diation of Npg leads to peptide backbone cleavage of func-
tional ion channels in vivo. Photolysis of the Npg-containing
channels resulted in the liberation of the inactivation ball from
the remainder of the channel, thereby slowing inactivation.
Because each channel contains four independent balls, with
only a single ball necessary to produce inactivation, the rate
and extent of inactivation depend on the number of balls (35).
The photolyzed channels are indistinguishable from channels
produced in systems expressing an appropriate mixture of ShB
and Shaker-IR, and, based on those studies, we estimated that
we have removed on average two of the four balls from ShB
channels after irradiation for 4 h.
Having established that Npg functions as designed using
ShB, we next turned our attention toward using Npg to probe
functional domains of the nicotinic acetylcholine receptor
(nAChR). The nAChR is the prototypical ligand-gated ion
channel, being the best studied member of a class that also
includes receptors for g-aminobutyric acid, glycine, and sero-
tonin (36–39). Structurally, the nAChR is formed by five
subunits arranged in a roughly pentagonal array. The muscle
form of the receptor has four homologous subunits with a2bgd
stoichiometry. Each subunit is thought to have a long extra-
cellular N-terminal region, followed by four transmembrane
segments and an extracellular C terminus (Fig. 3). Having
established that Npg can function when placed in a cytoplasmic
region of an ion channel protein, we wished to determine
whether it would also function in a transmembrane region.
Indeed, we found that incorporation of Npg at the crucial 99
site (40–44) (Leu262) in the second transmembrane region
(M2) of the b subunit (bLeu99Npg) gives a functional recep-
tor.§ Irradiation reduces the ACh-induced whole-cell current
by 50% (Fig. 3). As a control, oocytes expressing wild-type
nAChR were subjected to the same irradiation conditions, and
they exhibited no reduction in whole-cell current or change in
EC50.
Loss of ACh-induced current could result from a destruction
of the agonist binding site, a disruption of the gating pathway,
or some combination of the two. Alternatively, photolysis
could lead to a complete disruption of the protein, causing the
disassembly of the multisubunit structure. To probe this issue,
§As expected from previous studies on the effects of mutations that
change the polarity of residues at the 99 position (40–44), the more
polar Npg residue decreased EC50 relative to the wild-type Leu by a
factor of '20.
increase in noninactivating current for Pro64Npg mutant and wild-
type channels vs. irradiation time. Fractional noninactivating current
values were measured at 160 mV by dividing the steady-state current
(45 msec) by the peak current. More oocytes were irradiated for the
experiment of C than for B. Therefore, the UV lamp was defocused
to provide a uniform light intensity over a larger area. As such, light
intensity for C was severalfold reduced relative to B.
FIG. 2. (A) Schematic of the ShB channel, with the ball indicated
as an open circle. The inactivation process involves movement of the
ball and chain as suggested by the dashed line. The general region of
Npg incorporation is also noted. (B) Effect of irradiation on ShB
inactivation. Voltage–clamp currents for oocytes expressing ShB
wild-type and mutant channels during depolarizing jumps from a
holding potential of 280 mV to various test potentials between 280
and 160 mV. Leakage currents have been subtracted with a Py4
procedure. (1) Wild-type channels before irradiation; (2) Wild-type
channels after irradiation (4 h); (3) Pro64Npg mutant channel before
irradiation; (4) Pro64Npg mutant channels after irradiation (4 h). Note
that each panel corresponds to a different oocyte, so absolute current
values cannot be directly compared. (C) Photochemically induced
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we studied the binding of a-bungarotoxin and found that
receptors containing the b99 Npg mutation bind bungarotoxin
well. That the b99 mutation in M2 does not disrupt a-
bungarotoxin binding agrees with present ideas that this site is
buried in a transmembrane region, and the a-bungarotoxin
binding site substantially overlaps the agonist binding site,
which is thought to be well removed from the 99 site (36–39).
In addition, photolysis does not destroy toxin binding (Fig. 3).
Surface a-bungarotoxin binding requires a properly folded,
assembled receptor (45–47), so this result establishes that
Npg-induced photochemical proteolysis does not lead to total
destruction of the target protein but instead represents a local
distortion: cleavage of the peptide backbone.
We next turned to an intriguing feature of the nAChR that
seemed especially well suited to interrogation with Npg. A
highly conserved feature of the ligand-gated ion channel family
is the N-terminal disulfide loop, which in the muscle a subunit
runs from Cys128 to Cys142 (48–52). The function of this
structure has not been established. Several groups have at-
tempted to address this issue by conventional mutagenesis,
replacing one or more cysteines with serines, thereby prevent-
ing loop formation. However, this mutation leads to little or no
expression of functional protein, and it is now well understood
that disulfide loop formation is critical for proper subunit
folding and assembly (45–52). Similarly, selective reduction of
the a disulfide loop in the presence of analogous loops in the
other subunits and the highly reactive and functionally crucial
a C192-C193 disulfide is not feasible.
The key question is whether the signature loop has any
functional role in the receptor or whether its sole function is
to assist folding and assembly. The SNIPP approach allows a
natural way to address this issue. As shown in Fig. 3, intro-
ducing Npg within the disulfide loop would, after photolysis,
lead to a relatively local perturbation—destruction of a rela-
tively small loop while maintaining the disulfide bond. The
overall layout of the subunit would be intact because the
disulfide bond still exists. In contrast, the introduction of
Cys-to-Ser mutations could grossly perturb the structure of the
extracellular domain, and so it is not surprising that little or no
functional expression was seen in previous experiments involv-
ing such mutations.
Oocytes expressing nAChR channels containing an
aVal132Npg mutation showed ACh-induced currents with an
EC50 equal to that of wild-type nAChR channels. Thus,
channels containing the Npg mutation and an intact disulfide
loop assemble, fold, and function properly. Irradiation of these
oocytes led to an almost complete loss ('90%) of ACh-
induced, whole-cell current (Fig. 4). As noted above, oocytes
expressing wild-type nAChR also were subjected to UV irra-
diation, and they exhibited no reduction in whole-cell current
or change in EC50. These results establish that receptor
function requires the loop structure between the Cys128–
Cys142 disulfide bond in the a subunit. That is, in addition to
playing a key role in folding and assembly of the receptor, this
conserved structure is also essential for receptor function.
As before, loss of function could result from a destruction of
the agonist binding site, a disruption of the gating pathway, or
some combination of the two. This mutation is in the N-
terminal extracellular domain of the a subunit, a region that
is thought to contain most (or all) of the agonist binding site.
However, extensive affinity labeling and mutagenesis studies
have failed to establish any role in agonist or antagonist
binding for the signature disulfide loop. Nevertheless, although
the intact nAChR with the aVal132Npg mutation binds a-
FIG. 3. (A) Schematic of a nAChR subunit, showing the extracel-
lular N-terminal region and the four proposed transmembrane re-
gions. The sphere with a 1 indicates the agonist binding site region (a
subunits only) as suggested by affinity labeling and mutagenesis
studies. [Adapted from a figure by Changeux (38).] Also indicated are
the two sites where Npg was incorporated: V132 in the Cys128–Cys142
disulfide loop (a subunits) or the 99 position within the second
transmembrane (M2) region (b subunit). (B) Effect of irradiation on
the bLeu99Npg mutant. Oocytes were irradiated for 7.5 h. Whole-cell
currents are shown for mutant and wild-type receptors. ACh concen-
trations were 2.5 and 50 mM for mutant and wild type, respectively,
roughly equal to the EC50 values for the two (see text). When the
mutant receptor is activated with 25 mM ACh, comparable diminu-
tions of current are seen (data not shown). (C) [125I]-a-bungarotoxin
(a-Btx) binding to bLeu99Npg mutant receptor before and after
irradiation, using the same oocytes from B.
FIG. 4. Effects of irradiation on the aVal132Npg mutant receptor.
Oocytes were irradiated for 7.5 h. (A) Change in whole-cell current in
response to 200 mM ACh; (B) [125I]-a-bungarotoxin (a-Btx) binding
before and after irradiation using the same oocytes from A.
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bungarotoxin well, irradiation of the Npg-containing receptor
(but not the wild type) substantially reduces toxin binding (Fig.
4). This suggests that there may be some overlap between the
toxin binding site and the signature disulfide loop or that
cleavage of the loop leads to conformational changes else-
where in the a subunit that impact a-bungarotoxin binding.
The present results clearly establish that irradiation of the
Npg residue leads to cleavage of the peptide backbone with
significant functional consequences that can be evaluated
electrophysiologically, but several quantitative issues remain.
The long irradiation times required here indicate that Npg
photochemistry may be less efficient than in other related
systems (8–16). Additional work from our labs establishes that
more conventional nitrobenzyl caging groups can undergo very
efficient photolysis when incorporated into ion channel pro-
teins expressed in Xenopus oocytes (J. Miller, S. K. Silverman,
and P.M.E., unpublished work). Further work will be required
to characterize the source of these differences. Another issue
is the extent of photolysis, as indicated by loss of current. In the
nAChR, one site (aVal132Npg) produces a '90% reduction
in current, and another (bLeu99Npg) gives only a '50%
reduction under similar conditions. In both cases, controls
involving injection of full length, but uncharged, tRNA (4–6)
gave signals ,5% as large as those from oocytes injected with
Npg–tRNA, suggesting that essentially all receptors do contain
Npg. Future studies will address these issues.
CONCLUSIONS
The unnatural amino acid Npg can be efficiently incorporated
into ion channel proteins expressed in Xenopus oocytes, using
the in vivo nonsense suppression methodology. Irradiation of
Npg-containing proteins lead to site-specific cleavage of the
peptide backbone, regardless of whether the residue was
located in an intracellular (ShB positions 47 and 64), extra-
cellular (nAChR position a132), or transmembrane (nAChR
position bM2 99) region. Using SNIPP, we have established
that the signature disulfide loop of the a subunit of the nAChR
has a role beyond subunit folding and receptor assembly. The
loop must be intact for the receptor to function.
A notable feature of many ion channels and neuroreceptors
is their modular nature, often containing distinct domains that
can be assigned specific functional roles such as gating vs.
ligand binding. Conventional efforts to evaluate the separate
roles of such domains, typically by expressing two separately
synthesized peptides, often, with a few notable exceptions
(53–55), lead to failure of expression andyor function of the
receptor. The SNIPP strategy overcomes this limitation by first
producing intact, functional, properly localized protein and
subsequently introducing the backbone lesion photochemi-
cally. Future challenges include modification of the Npg
residue to improve the efficiency and rate of photolysis, but
already Npg provides a valuable structural probe for proteins
expressed in intact cells. We anticipate application of SNIPP
in further studies of ion channels and also in evaluating the
roles of specific proteins in signal transduction pathways.
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